Fundraising Fox

Amani Therapeutics

New York, US · Founded 2025 · Delaware corporation · 1 known investors

Healthtech

Founders & leadership

AL
Alice LeeNamed on SEC filing

Investors · 1

RTW Investments L.P.reportedNew York

Reported raises · per SEC filings

Form D private placements

$31.1M disclosed across 1 round · 2025

▶$31.1MraisedDec 2025 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Alice LeeExecutive Officer, Director
  • -- RTW Holdings VI, LLCPromoter
Offering amount
$31.1M
Amount sold
$31.1M
First sale
Nov 2025
Incorporated
Corporation, Delaware, 2025
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Amani Therapeutics: $25 Million Raised To Advance Neuropsychiatric Therapy AM-01pulse2.com · Mar 2026Amani raises USD 25m Series A, in-licenses AZ compound for clozapine FDC - AllSciallsci.com · Mar 2026Amani Therapeutics Raises $25M in Series A Fundingfinsmes.com · Mar 2026Amani Therapeutics Targets Clozapine’s Adoption Cliff With Fixed-Dose Safety Play—Can It Unlock a $100B Market?ainvest.com · Mar 2026Amani Therapeutics Closes $25 Million Series A to Advance AM-01, a Potential Best-in-Class Therapy for Serious Neuropsychiatric Disorders - BioSpacebiospace.com · Mar 2026

Frequently asked questions

Who are Amani Therapeutics's investors?
Amani Therapeutics's investors include RTW Investments L.P..
How much funding has Amani Therapeutics raised?
Amani Therapeutics has disclosed $31.1M raised across 1 round.
Where is Amani Therapeutics headquartered?
Amani Therapeutics is headquartered in New York, US.